If you made any changes in Pure these will be visible here soon.

Personal profile

Education

  • 2008 PhD (Epidemiology), Rutgers School of Public Health
  • 2000 MHS, Johns Hopkins University-School of Public Health

Experience

  • 2014- Associate Professor, Taipei Medical University
  • 2014 Adjunct Associate, Professor, Rutgers School of Public Health, 
  • 2012 Assistant Professor, Robert Wood Johnson medical school 

Research Interests

  • Epidemiology, Pharmacoepidemiology, Data Science, Comparative-Effectiveness study

Fingerprint Dive into the research topics where Yu-Hsuan Shao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Proton Pump Inhibitors Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Androgens Medicine & Life Sciences
Mortality Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2020

先天DNA修補基因突變與前列腺癌風險與癒後

Shao, Y.

8/1/197/1/20

Project: A - Government Institutionb - Ministry of Science and Technology

整合早發型前列腺癌臨床與分子特徵於癌症風險分類之應用

Shao, Y.

8/1/187/31/19

Project: B - Project of TMUh - Other (Funded by TMU)

探討前列腺癌病患接受去雄性激素療法之癒後及併發代謝症候群對於病程的影響與可能的藥物預防(3/3)

Shao, Y.

8/1/177/31/18

Project: A - Government Institutionb - Ministry of Science and Technology

建立多構面癌症防治預測模式:以大腸癌為例-建立多構面癌症防治預測模式:以大腸癌為例

Shao, Y.

9/1/158/31/16

Project: A - Government Institutionb - Ministry of Science and Technology

Research Output 2007 2019

  • 953 Citations
  • 13 h-Index
  • 23 Article
  • 2 Conference contribution
  • 1 Book
  • 1 Letter
1 Citation (Scopus)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Androgens
Prostatic Neoplasms
Mortality
Therapeutics
10 Citations (Scopus)
Proton Pump Inhibitors
Hepatocellular Carcinoma
Confidence Intervals
Hepatitis C
Hepatitis B
1 Citation (Scopus)

Evaluation of carrier size and surface morphology in carrier-based dry powder inhalation by surrogate modeling

Kazemzadeh Farizhandi, A. A., Pacłaawski, A., Szlęk, J., Mendyk, A., Shao, Y-H. J. & Lau, R., Sep 1 2018

Research output: Book/ReportBook

Proton Pump Inhibitors
Hepatocellular Carcinoma